The KPNA5 Knockout NCI-H1975 Polyclonal Cells product comprises a population of CRISPR/Cas9-edited NCI-H1975 lung adenocarcinoma cells with targeted disruption of the KPNA5 gene. This polyclonal knockout pool provides a heterogeneous loss-of-function model for studying importin alpha 5-dependent nuclear transport processes. The cells have undergone CRISPR/Cas9-mediated gene editing to abolish KPNA5 expression, enabling investigation of its role in nucleocytoplasmic trafficking without the need for single-cell cloning.
The host cell line, NCI-H1975, is a well-characterized human non-small cell lung adenocarcinoma cell line derived from a female non-smoker. It harbours clinically relevant mutations, including the EGFR T790M gatekeeper mutation in the tyrosine kinase domain and a PIK3CA mutation, which drive oncogenic signaling pathways. These mutations make NCI-H1975 a valuable model for studying EGFR-mutant lung cancer and for evaluating therapeutic strategies targeting EGFR and downstream effectors.
KPNA5, also known as importin alpha 5, functions as an adaptor protein in the classical nuclear import pathway. It recognizes cargo proteins containing classical nuclear localization signals (NLS), such as transcription factors STAT1, TP53, and NF-??B (RELA), and forms a trimeric complex with importin beta (KPNB1). This complex translocates through the nuclear pore complex via interactions with FG-nucleoporins, including NUP62. The translocation is terminated by Ran GTPase, which disassembles the complex upon binding GTP in the nucleus, releasing the cargo. KPNA5 activity is regulated by upstream signals such as EGF/EGFR signaling and interferon-gamma (IFNG), and its depletion disrupts the nuclear import of key transcription factors, thereby altering downstream gene expression programs.
In the NCI-H1975 background, KPNA5 knockout is particularly significant due to the dependence of EGFR-mutant lung cancer cells on nucleocytoplasmic shuttling of transcription factors like STAT1, NF-??B, and TP53. The EGFR T790M mutation leads to sustained activation of downstream pathways that may intersect with nuclear transport regulation. Loss of KPNA5 can impair the nuclear localization of these regulators, potentially affecting cell proliferation, apoptosis, and drug sensitivity. This model thus allows dissection of how nuclear import adaptor paralog specificity contributes to oncogenic signaling in a genetic context relevant to lung adenocarcinoma.
Researchers can employ these KPNA5 knockout polyclonal cells in a range of assays to investigate nuclear transport mechanisms and cancer biology. Immunofluorescence microscopy can assess changes in the subcellular distribution of NLS-bearing proteins, while subcellular fractionation followed by western blotting permits quantification of nuclear versus cytoplasmic accumulation. Transcriptome profiling via RNA-seq reveals global gene expression alterations resulting from impaired nuclear import. Functional studies may include nuclear import reconstitution assays with digitonin-permeabilized cells to dissect transport factor requirements. Additionally, these cells are suitable for assessing drug responses to importin inhibitors, such as ivermectin, and for screening compounds that modulate nucleocytoplasmic trafficking. For detailed technical information and ordering, please contact Ascent Research.
